Supplementary Figure S2 from Preclinical Efficacy of the Auristatin-Based Antibody–Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors

Authors :: Bertolt Kreft
Karl Ziegelbauer
Hung Huynh
Rolf Jautelat
Heiner Apeler
Frank Reetz
Frank Dittmer
Axel Harrenga
Sabine Wittemer-Rump
Ruprecht Zierz
Manuela Braun
Joachim Schuhmacher
Simone Greven
Stefanie Hammer
Beatrix Stelte-Ludwig
Hans-Georg Lerchen
Christoph Mahlert
Carl F. Nising
Christoph A. Schatz
Charlotte Kopitz
Anette Sommer
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: The anti-tumor efficacy of different FGFR2-ADC BAY 1187982 treatment schedules on MFM-223 human TNBC mouse model.

Full Text Access

Tools